Meloxicam EP Impurity C

A validated RP-HPLC method for determination of Meloxicam in the Presence of its Impurities.
Purushotam K. Sinha1 , Rajesh M. Jeswani1 , Kirti S. Topagi1 , Mrunalini C. Damle
International Journal of PharmTech Research Vol.1, No.4, pp 1051-1060
 
Manufacture of High-Purity Meloxicam via Its Novel Potassium Salt Monohydrate
Tibor Mezei,§ Norbert Mesterha´zy,‡ Tibor Bako´,§ Ma´rta Porcs-Makkay,§ Gyula Simig,§ and Bala´zs Volk
Organic Process Research & Development 2009, 13, 567–572
 
A Review of HPLC Methods Used for Determining the Presence of Meloxicam
Monika Brezovska*, Josef Jampilek and Radka Opatrilova
Current Pharmaceutical Analysis, 2013, Vol. 9

Meloxicam EP Impurity C is chemically N-[(2Z)-3,5-dimethylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide. Meloxicam EP Impurity C is supplied with detailed characterization data compliant with regulatory guideline. Meloxicam EP Impurity C can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Meloxicam.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.